Literature DB >> 21328153

Economic aspects of mastitis: new developments.

H Hogeveen1, K Huijps, T J G M Lam.   

Abstract

Good udder health is not only important for the dairy farmer but, because of increasing interest of consumers in the way dairy products are produced, also for the dairy production chain as a whole. An important role of veterinarians is in advising on production diseases such as mastitis. A large part of this advice is given around the planning of management to maintain or improve the udder health status of a farm. Mastitis is a costly disease, due to losses (a reduction of output due to mastitis) and expenditure (additional inputs to reduce the level of mastitis). Worldwide, published estimates of the economic losses of clinical mastitis range from €61 to €97 per cow on a farm, with large differences between farms, e.g. in The Netherlands, losses due to clinical and subclinical mastitis varied between €17 and €198 per cow per year. Moreover, farmers tended to underestimate these costs. This indicates that for a large proportion of farms there are many avoidable losses. In order to provide good support to farmers' decision-making, it is important to describe the mastitis setting not only in terms of disease, e.g. incidence of clinical mastitis, but also in monetary terms; and to make good decisions, it is necessary to provide the dairy farmer with information on the additional expenditure and reduced losses associated with alternative decisions. Six out of 18 preventive measures were shown to have a positive nett benefit, viz blanket use of dry-cow therapy, keeping cows standing after milking, back-flushing of the milk cluster after milking a cow with clinical mastitis, application of a treatment protocol, washing dirty udders, and the use of milkers' gloves. For those measures that included a large amount of routine labour or investment, the reduced losses did not outweigh the additional expenditure. The advisor cannot expect that measures that are cost-effective are always implemented. Reasons for this are the objectives of the dairy farmer can be other than maximisation of profit, resources to improve the mastitis situation compete with other fields of management, risk involved with the decision, economic behaviour of the dairy farmer, and valuation of the cost factors by the dairy farmer. For all decision-makers this means that, although financial incentives do have an effect on the management of mastitis, it is not always sufficient to show the economic benefits of improved management to induce an improvement of management of mastitis.

Entities:  

Mesh:

Year:  2011        PMID: 21328153     DOI: 10.1080/00480169.2011.547165

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  89 in total

Review 1.  Immunopathology of mastitis: insights into disease recognition and resolution.

Authors:  Stacey L Aitken; Christine M Corl; Lorraine M Sordillo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09-22       Impact factor: 2.673

2.  Stevioside plays an anti-inflammatory role by regulating the NF-κB and MAPK pathways in S. aureus-infected mouse mammary glands.

Authors:  Tiancheng Wang; Mengyao Guo; Xiaojing Song; Zecai Zhang; Haichao Jiang; Wei Wang; Yunhe Fu; Yongguo Cao; Lianqin Zhu; Naisheng Zhang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  Changes in genetic selection differentials and generation intervals in US Holstein dairy cattle as a result of genomic selection.

Authors:  Adriana García-Ruiz; John B Cole; Paul M VanRaden; George R Wiggans; Felipe J Ruiz-López; Curtis P Van Tassell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

4.  Selected reaction monitoring mass spectrometry of mastitis milk reveals pathogen-specific regulation of bovine host response proteins.

Authors:  Ulrike Kusebauch; Lorenzo E Hernández-Castellano; Stine L Bislev; Robert L Moritz; Christine M Røntved; Emøke Bendixen
Journal:  J Dairy Sci       Date:  2018-04-11       Impact factor: 4.034

5.  Meta-analysis of the prevalence of mastitis and associated risk factors in dairy cattle in Ethiopia.

Authors:  Abraham Mekibeb Getaneh; Endrias Zewdu Gebremedhin
Journal:  Trop Anim Health Prod       Date:  2017-02-09       Impact factor: 1.559

6.  Characterisation of mecA gene negative Staphylococcus aureus isolated from bovine mastitis milk from Northern Germany.

Authors:  O H Sheet; N T Grabowski; G Klein; F Reich; A Abdulmawjood
Journal:  Folia Microbiol (Praha)       Date:  2019-03-19       Impact factor: 2.099

7.  Prediction of key regulators and downstream targets of E. coli induced mastitis.

Authors:  Somayeh Sharifi; Abbas Pakdel; Esmaeil Ebrahimie; Yalda Aryan; Mostafa Ghaderi Zefrehee; James M Reecy
Journal:  J Appl Genet       Date:  2019-06-11       Impact factor: 3.240

8.  A systematic review and meta-analysis of prevalence of subclinical mastitis in dairy cows in India.

Authors:  Yogesh Chandrakant Bangar; Bishwambhar Singh; Amit Kumar Dohare; Med Ram Verma
Journal:  Trop Anim Health Prod       Date:  2014-11-19       Impact factor: 1.559

9.  Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial.

Authors:  Geoffrey Truchetti; Emile Bouchard; Luc Descôteaux; Daniel Scholl; Jean-Philippe Roy
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

10.  Formation of NET, phagocytic activity, surface architecture, apoptosis and expression of toll like receptors 2 and 4 (TLR2 and TLR4) in neutrophils of mastitic cows.

Authors:  Dilip K Swain; Mohar Singh Kushwah; Mandheer Kaur; Tapas K Patbandha; Ashok K Mohanty; Ajay K Dang
Journal:  Vet Res Commun       Date:  2014-06-12       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.